Starch Softgel Capsules Market is expected to reach US$ 548.29 Mn by 2027

Starch Softgel Capsules Market for Health Supplements to Grow at Highest CAGR during 2020–2027

According to our new market research study on "Starch Softgel Capsules Market to 2027 – Global Analysis and Forecast – by Application and Distribution Channel," the market is expected to reach US$ 548.29 million by 2027 from US$ 382.67 million in 2019. The market is estimated to grow with a CAGR of 4.7% from 2020 to 2027. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth.

Based on application, the market is segmented in to health supplements, pharmaceutical, and others. In 2019, the health supplements segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to factors such as capability of softgels to mask odors, elegant in appearance, and easier for swallowing.  Moreover, these formulations are considered ideal as they improve the bioavailability and enhance the absorption of essential nutrients. Vitamin and mineral supplements are the commonly preferred starch softgel health supplements. Additionally, increasing awareness among populace regarding the benefits of health and fitness along with high consumption of sports-associated health nutritional supplements are likely to augment the growth of the segment.

Factors such as increasing availability of vegetarian softgel capsules and rising preference of pharmaceutical and nutraceutical companies toward softgel capsules are expected to boost the growth of the global starch softgel capsules market. However, the market is likely to get impacted by the difficulties in optimizing cellulose/starch for API delivery during the forecast period.

Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH, Sirio Pharma Co., Ltd., and Bahrain Pharma are among the leading companies operating in the starch softgel capsules market.

Starch Softgel Capsules Market, by Region, 2019 (%)

---

Starch Softgel Capsules Market to Grow at a CAGR of 4.7% to reach US$ 548.29 Million from 2020 to 2027

Download Free Sample

---

Starch Softgel Capsules Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider), and Geography

The Report Segments Global Starch Softgel Capsules Market as Follows:

By Application

• Health Supplements
• Pharmaceutical
• Others

By Distribution Channel

• Supermarket and Hypermarket
• Pharmacy and Drugstore
• Online Provider

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina